Masayuki Yokoyama

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia

C. Nakaseko, A. Tawada, T. Chiba, 2017, Case Reports in Gastroenterology.

Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan

N. Sugiura, N. Kato, T. Kanda, 2019, Investigational New Drugs.

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma

M. Miyazaki, A. Iwama, O. Yokosuka, 2017, Oncotarget.

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

H. Nomura, H. Yoshiji, M. Matsuda, 2021, Journal of Gastroenterology.

Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment

O. Yokosuka, N. Kato, T. Kanda, 2018, Investigational New Drugs.

Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials

M. Miyazaki, O. Yokosuka, N. Kato, 2020, Liver Cancer.